| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,088 |
13,613 |
$1.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,432 |
7,042 |
$399K |
| 99215 |
Prolong outpt/office vis |
481 |
449 |
$53K |
| 36415 |
Collection of venous blood by venipuncture |
9,495 |
8,874 |
$38K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,116 |
1,103 |
$26K |
| 97803 |
|
578 |
533 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
644 |
622 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
627 |
605 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,954 |
1,915 |
$17K |
| 90686 |
|
1,986 |
1,944 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,443 |
1,419 |
$15K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
175 |
173 |
$13K |
| 90834 |
Psychotherapy, 45 minutes with patient |
173 |
140 |
$13K |
| 80061 |
Lipid panel |
1,118 |
1,095 |
$13K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
146 |
142 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
593 |
581 |
$9K |
| 81514 |
|
33 |
33 |
$8K |
| 80053 |
Comprehensive metabolic panel |
845 |
833 |
$8K |
| 90837 |
Psychotherapy, 53 minutes with patient |
68 |
55 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
75 |
75 |
$6K |
| X5622 |
|
830 |
802 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
201 |
196 |
$5K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,042 |
2,015 |
$5K |
| 87481 |
|
141 |
137 |
$5K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
133 |
130 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
174 |
172 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
438 |
428 |
$3K |
| 92551 |
|
624 |
616 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
503 |
480 |
$3K |
| 99188 |
|
351 |
350 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
25 |
24 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
36 |
36 |
$2K |
| 0064A |
|
64 |
62 |
$2K |
| 85027 |
|
386 |
368 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
12 |
12 |
$2K |
| 81025 |
|
232 |
222 |
$1K |
| 90656 |
|
68 |
67 |
$904.94 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
49 |
49 |
$877.91 |
| 86803 |
|
63 |
62 |
$815.46 |
| 87210 |
|
198 |
192 |
$721.26 |
| 0012A |
|
30 |
30 |
$718.68 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
37 |
28 |
$711.77 |
| 80050 |
General health panel |
12 |
12 |
$625.16 |
| 86780 |
|
59 |
55 |
$606.37 |
| 0011A |
|
42 |
42 |
$590.44 |
| 99173 |
|
456 |
447 |
$552.09 |
| 0134A |
|
12 |
12 |
$471.83 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
18 |
12 |
$438.68 |
| 99177 |
|
159 |
158 |
$429.06 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
35 |
33 |
$398.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
97 |
97 |
$280.82 |
| 81001 |
|
112 |
105 |
$205.62 |
| 85018 |
|
81 |
79 |
$184.19 |
| 82728 |
|
12 |
12 |
$174.67 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
12 |
$150.16 |
| 87081 |
|
47 |
46 |
$101.88 |
| G0008 |
Administration of influenza virus vaccine |
48 |
40 |
$71.84 |
| 90672 |
|
12 |
12 |
$48.16 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
38 |
29 |
$47.97 |
| 90688 |
|
14 |
14 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
38 |
38 |
$0.00 |
| 90670 |
|
38 |
38 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |